Results 1 to 10 of about 116,023 (167)
COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report
Thrombosis Update, 2021 Sickle cell trait (SCT) is the carrier state for sickle cell disease (SCD) and is usually perceived as a mild condition; however, previous studies have shown that hypoxemia may trigger sickle-cell related complications in these patients, including ...
Álvaro Alejandre-de-Oña +4 more
doaj +1 more source
Thrombosis Update, 2022 HELLP syndrome consists of the triad hemolysis, elevated liver enzymes and low platelets count. It is usually developed in pregnant women with preeclampsia. Intrahepatic liver hematoma is an extremely rare complication of HELLP syndrome.
E. Cervilla-Muñoz +6 more
doaj +1 more source
Risk stratification scores for major bleeding in patients with venous thromboembolism
Spanish Journal of Medicine, 2021 The standard treatment for venous thromboembolism (VTE) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient’s preferences.
Francisco Galeano-Valle +2 more
doaj +1 more source
TH Open, 2021 Introduction Dose adjustment based on laboratory monitoring is not routinely recommended for patients treated with rivaroxaban but because an association has been reported between high drug level and bleeding, it would be of interest to know if measuring
Krishnan Shyamkumar +5 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2023 We present an extremely rare case of a patient with intermediate-high risk pulmonary embolism treated with percutaneous mechanical thrombectomy, complicated with stroke as a form of paradoxical embolism through a previously unknown patent foramen ovale ...
Marina López-Rubio +7 more
doaj +1 more source
Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension
Cardiology Journal, 2020 BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of venous thromboembolism (VTE) resulting from non-dissolving thromboemboli in the pulmonary arteries.
Monika Sznajder +6 more
doaj +1 more source
Beyond ChatGPT: What does GPT-4 add to healthcare? The dawn of a new era
Cardiology Journal, 2023 Over the past few years, artificial intelligence (AI) has significantly improved healthcare. Once the stuff of science fiction, AI is now widely used, even in our daily lives — often without us thinking about it. All healthcare professionals — especially
Simona Wójcik +5 more
doaj +1 more source
Inflammatory bowel disease and superior mesenteric artery thromboembolism [PDF]
Intestinal Research, 2020 While patients with inflammatory bowel disease are known to be at increased risk of venous thromboembolism, the risk of arterial thrombosis is less well recognized.
Steven Nicolaides +2 more
doaj +1 more source
BMC Pulmonary Medicine, 2018 Background Approximately a quarter of patients with advanced sarcoidosis develop pulmonary hypertension (PH), which affects their prognosis. We report unusual case of confirmed chronic thromboembolic pulmonary hypertension (CTEPH) in a patient with stage
Andrzej Labyk +10 more
doaj +1 more source
British Medical Bulletin, 2003 Venous thomboembolism (VTE) causes only about 2% of maternal deaths in the developing world but is a leading cause of direct maternal deaths in developed countries. Pregnancy increases the risk of VTE through venous stasis, changes in blood coagulability and damage to vessels.
openaire +2 more sources